The Effects of Logos’ Frames on Consumers’ Psychological Perceptions and Brand Attitudes
Journal of Economics and Public Finance · 2024
DOI: 10.22158/jepf.v10n1p40 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Economics and Public Finance, 2024. Verfasst von Minting Zhao und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study examined the effects of the brand logo’s frames (complete vs. incomplete) on consumers’ perceptions and attitudes. There were 452 participants in two studies online. The results show that the brand logos with complete (vs. incomplete) frames have higher safety (in Study 1). Moreover, the logos’ frames of complete (vs. incomplete) brands will generate the positive brand attitudes through increasing the consumers’ psychological perception of safety. For products with high safety attributes, consumers will have a higher evaluation of the brand logos with the complete frames, but there is no effect for products with less important safety attributes (in Study 2). This paper provides some guidance for the research of consumers’ psychological perceptions, and also broadens the scope of application of the conceptual metaphor.
Zitieren
APA
Zhao, M., Chen, D., Wei, Y., Yang, F., & Zhang, Y. (2024). The Effects of Logos’ Frames on Consumers’ Psychological Perceptions and Brand Attitudes. Journal of Economics and Public Finance. https://doi.org/10.22158/jepf.v10n1p40
Vancouver
Zhao M, Chen D, Wei Y, Yang F, Zhang Y. The Effects of Logos’ Frames on Consumers’ Psychological Perceptions and Brand Attitudes. Journal of Economics and Public Finance. 2024. doi:10.22158/jepf.v10n1p40
BibTeX
@article{Zhao2024,
author = {Zhao, Minting and Chen, Dan and Wei, Yiwei and Yang, Fo and Zhang, Yongqiang},
title = {The Effects of Logos’ Frames on Consumers’ Psychological Perceptions and Brand Attitudes},
journal = {Journal of Economics and Public Finance},
year = {2024},
doi = {10.22158/jepf.v10n1p40}
}
EUVIMED